Navigation Links
Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients
Date:11/1/2008

ith hypersensitivity to ribavirin or any other component of the product, women who are pregnant, men whose female partners are pregnant, patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia), and patients with creatinine clearance less than 50 mL/min.

Avoid Pregnancy

REBETOL therapy should not be started until a report of a negative pregnancy test has been obtained immediately prior to planned initiation of therapy. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients during therapy and 6 months post-treatment. Patients should use at least two effective forms of contraception and have monthly pregnancy tests during therapy and for 6 months after completion of therapy. A Ribavirin Pregnancy Registry has been established to monitor maternal-fetal outcomes of pregnancies in female patients and female partners of male patients exposed to ribavirin during treatment, and for 6 months following cessation of treatment. Physicians and patients are encouraged to report such cases by calling 1-800-593-2214.

Incidence of Adverse Events

There are no new adverse events specific to PEGINTRON as compared to INTRON A; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. The most common adverse events associated with PEGINTRON were "flu-like" symptoms, occurring in approximately 50% of patients, which may decrease in severity as treatment continues. Application site disorders were common (47%), but all were mild (44%) or moderate (4%) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving PEGINTRON. Alopecia (thinning of the hair) is also often associated with alpha interferons including PEGINTRON.

Psychiatric adverse events, which include insomnia, were common (57%) with PEGINTRON but similar to INTRO
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
2. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
3. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
4. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
5. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
6. Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
9. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... grade hypothermic storage and cryopreservation freeze ... for cells and tissues  ("BioLife" or the "Company"), today ... will be released on Thursday, August 6, 2015, and ... live webcast at 1:30 p.m. PT that afternoon. Management ...
(Date:7/29/2015)... Wash. , NEW YORK ... July 29, 2015  CMC Biologics, a global ... proteins, and River Vision Development Corporation (River Vision), a ... they have entered into an agreement for the ... – a recombinant monoclonal antibody targeting insulin-like growth ...
(Date:7/29/2015)... LLC, The Lawsuit Settlement Funding Company, announced today that U.S. ... of West Virginia (W.Va) pushed back ... start in November. The first trial that was set included ... now it involves 39 women, and the trial has been ... article in Reuters. The alterations were made after data emerged ...
Breaking Medicine Technology:BioLife Solutions to Report Second Quarter 2015 Financial Results and Provide Business Update on August 6, 2015 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 3Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... 2010 Reportlinker.com announces that a new market ... Women,s Health Diagnostic Testing ... of this TriMark Publications report is to describe ... (IVDs) market called women,s health testing. This study ...
... YORK, Dec. 29, 2010 Reportlinker.com announces that ... its catalogue: The Outlook for ... http://www.reportlinker.com/p0203102/The-Outlook-for-Pharmaceuticals-in-Central-Asia.html The Outlook for Pharmaceutical ... management reports from Espicom Business Intelligence. Each report ...
Cached Medicine Technology:Reportlinker Adds Women's Health Diagnostic Testing 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 2Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia 3
(Date:7/29/2015)... , ... July 29, 2015 , ... Wedding season is in full swing, which means ... extra pressure of looking good on the big day. Every bride wants to look and ... new level. , According to a recent study by the American ...
(Date:7/29/2015)... ... ... We are privileged to announce that U.S. News & World Report has ranked ... in the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye ... an honor to be included in the top 10 ophthalmology hospitals by U.S. News & ...
(Date:7/29/2015)... ... 29, 2015 , ... CanAm Enterprises, LLC (“CanAm”) is thrilled to announce that ... approvals have been granted to investors in four different CanAm EB-5 projects -- the ... in Philadelphia, and the Valley Forge Convention Center project in CanAm’s regional center in ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... of American Farmer, airing fall of 2015 on RFD-TV. , Fastline is dedicated ... will learn about Fastline.com, which contains the largest and freshest searchable agriculture equipment ...
(Date:7/29/2015)... ... ... Awareness Month, and in honor of this month, Dr. Melda Isaac of MI-Skin Dermatology and ... as well as how to best treat existing sun damage. Sun damage can range from ... America. Many people do not protect their skin sufficiently when going out in the sun, ...
Breaking Medicine News(10 mins):Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3
... (June 10, 2008) The Endocrine Society ... investigator at Los Angeles Biomedical Research Institute at ... Educator Award during its annual convention June 15-18 ... international association of 13,000 members representing the full ...
... 2008) Screening for lung cancer with computed tomography (CT) ... smokers, but it won,t protect them from other causes of ... in the July issue of the journal Radiology . ... way to reduce risk of death from lung cancer," said ...
... Middle- and upper-income families find it harder to get needed ... -- The number of American adults who had inadequate health ... 2003 to 2007, from 16 million to more than 25 ... higher incomes, those whose income was 200 percent above the ...
... That Include,Avastin, Erbitux, Rituxan/MabThera, According to a New Report from Decision ... ... Mass., June 10 Decision Resources, one of the,world,s leading research ... antibodies (MAbs) drug market,will more than double to $16.7 billion in ...
... SCOTTSDALE, Ariz., June 10 Examination Management,Services, ... retrieval services,in the nation, and Cybersettle, the ... to provide Cybersettle users with integrated,medical record ... of,claim disputes., Combining Cybersettle,s Web-based dispute ...
... Announce Plans for Celebrating World Blood Donor,Day on ... To increase national,and global appreciation of volunteer blood ... (ADRP) are partnering together to,encourage their respective members ... 14. This specific day marks the birthday of ...
Cached Medicine News:Health News:LA BioMed investigator wins Distinguished Educator Award 2Health News:CT lung cancer screening no cure-all for smokers 2Health News:25 Million Americans Are 'Underinsured' 2Health News:25 Million Americans Are 'Underinsured' 3Health News:25 Million Americans Are 'Underinsured' 4Health News:The Monoclonal Antibodies Drug Market for the Treatment of Cancer Will More Than Double to $16.7 Billion By 2016 2Health News:EMSI and Cybersettle Partner to Provide Cybersettle Clients With Medical Record Retrieval Services 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 3Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 4
... is a precise, reliable and technologically ... been designed for OEM production. Its ... according to the method bottles size., ... to process automatically the whole ELISA ...
The GEM OPL CO-Oximeter provides comprehensive oxygenation status in an easy-to-use, portable manner. The GEM OPL is the ideal solution for laboratory or point-of-care CO-Oximetry testing....
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
The ImmunoWELL Mycoplasma Pneumoniae Antibody (IgM) Test is a qualitative enzyme immunoassay (EIA) for the detection of specific IgM antibodies to M. pneumoniae in serum and is an aid in the diagnosi...
Medicine Products: